A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-Controlled, Safety, Tolerability, and Efficacy Study of Oxycodone DETERx Versus Placebo in Opioid-Experienced and Opioid-Naive Subjects With Moderate-to-Severe Chronic Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Oxycodone (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Collegium Pharmaceutical
- 16 Mar 2017 According to a Collegium media release, post hoc analysis data will be presented at the 33rd Annual American Academy of Pain Medicine Meeting.
- 01 Sep 2016 According to Collegium media release, post hoc analysis data will be presented at PAINWeek 2016.
- 14 May 2016 Results of a sub-group post-hoc analysis (n=26) presented at the 35th Annual Scientific Meeting of the American Pain Society